Triggers of histologically suspected drug-induced colitis

doi:10.3748/wjg.v25.i8.967

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 25, Issue 8

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (11479)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-6) series.

Item

Count

PDF

588

WORD

173

HTML

7834

Figures (1-2)

210

Tables (1-6)

234

Sum=9039

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

887

Download

1553

Sum=2440

Feb 28, 2019 (publication date) through May 5, 2024

Times Cited of This Article

Times Cited (15)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Control Study

World J Gastroenterol. Feb 28, 2019; 25(8): 967-979
Published online Feb 28, 2019. doi: 10.3748/wjg.v25.i8.967

Table 4 Drug assessment n (%)

Group	Drug-induced colitis, n = 211	Non-inflammatory controls, n = 211	Inflammatory controls, n = 211
Betablocker	97 (46.0)	78 (37.0)	83 (39.3)
ACE inhibitors	70 (33.2)	55 (26.1)	62 (29.4)
Angiotensin II inhibitors	20 (9.5)^b¹	24 (11.4)	6 (2.8)^b³
Non-Dihydropyridines	1 (0.5)^a¹	6 (2.8)	7 (3.3)
Dihydropyridines	34 (16.1)^a¹	27 (12.8)	20 (9.5)
Diuretics	55 (26.1)^b¹	29 (13.7)^b²	33 (15.7)
Benzothiazines	28 (13.3)	33 (15.6)	24 (11.4)
Aldosterone antagonists	13 (6.2)	13 (6.2)	12 (5.7)
Nitrates	7 (3.3)	13 (6.2)	5 (2.4)
Antiarrhythmic drugs	7 (3.3)	2 (0.9)	2 (0.9)
Glycosides	10 (4.7)	2 (0.9)^a²	8 (3.8)
ASS (100 mg to 300 mg)	67 (31.8)^b¹	47 (22.3)^a²	40 (19.0)
Platelet aggregation inhibitors	20 (9.5)^b¹	10 (4.7)	6 (2.8)
NSAIDs	35 (16.6)^b¹	21 (10.0)^a²	8 (3.8)^a³
Metamizole	21 (10.0)	16 (7.6)	21 (10.0)
Potassium	4 (1.9)	3 (1.4)	6 (2.8)
Vitman K antagonists/coumarin derivates	16 (7.6)	9 (4.3)	11 (5.2)
Direct thrombin inhibitors	6 (2.8)	2 (0.9)	4 (1.9)
Glucocorticosteroids	13 (6.2)^b¹	14 (6.6)	41 (19.4)^b³
Opioids	20 (9.5)	22 (10.4)	23 (10.9)
Metformin	8 (3.8)	16 (7.6)	4 (1.9)^b³
Insulin	17 (8.1)	15 (7.1)	17 (8.1)
Statins	56 (26.5)^a¹	42 (19.9)	38 (18.0)
Fibrates	7 (3.3)^a¹	1 (0.5)^a²	1 (0.5)
Levothyroxine	25 (11.8)	39 (18.5)	22 (10.4)^a³
Thyreostatics	3 (1.4)	3 (1.4)	1 (0.5)
Proton pump inhibitors	100 (47.4)	85 (40.3)	81 (38.4)
Penicillin derivates	0 (0.0)	2 (0.9)	2 (0.9)
Macrolides	0 (0.0)	1 (0.5)	1 (0.5)
Gyrase inhibitor	0 (0.0)	0 (0.0)	0 (0.0)
Carbapenems	1 (0.5)	0 (0.0)	0 (0.0)
Imidazoles	3 (1.4)	1 (0.5)	1 (0.5)
Cephalosporins	2 (0.9)	2 (0.9)	2 (0.9)
Antbiotics	4 (1.9)	5 (2.4)	3 (1.4)
SSRIs	14 (6.6)	5 (2.4)^a²	16 (7.6)^a³
Tricyclic antidepressants	7 (3.3)	10 (4.7)	7 (3.3)
Neuroleptics	5 (2.4)	8 (3.8)	6 (2.8)
Sedatives	16 (7.6)	16 (7.6)	16 (7.6)
Others	127 (60.2)^a¹	125 (59.2)	147 (69.7)^a³
Number of drugs^b	4.5 ± 2.8	3.9 ± 3.0^a²	3.9 ± 3.2

¹Drug-induced colitis vs inflammatory controls.

²Drug-induced colitis vs non-inflammatory controls.

³Non-inflammatory controls vs inflammatory controls.

^aP < 0.05.

^bP < 0.01.

Statistical analysis was carried out with χ² test (a) or t-test (b). NSAIDs : Nonsteroidal anti-inflammatory drugs; SSRIs: Selective serotonin reuptake inhibitors; ACE: Angiotensin-converting enzyme.

Citation: Brechmann T, Günther K, Neid M, Schmiegel W, Tannapfel A. Triggers of histologically suspected drug-induced colitis. World J Gastroenterol 2019; 25(8): 967-979
URL: https://www.wjgnet.com/1007-9327/full/v25/i8/967.htm
DOI: https://dx.doi.org/10.3748/wjg.v25.i8.967